LEXICON PHARMACEUTICALS INC's ticker is LXRX and the CUSIP is 528872302. A total of 140 filers reported holding LEXICON PHARMACEUTICALS INC in Q1 2017. The put-call ratio across all filers is 1.21 and the average weighting 0.9%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2016 | $433,000 | -37.1% | 31,283 | -17.9% | 0.02% | -21.9% |
Q3 2016 | $688,000 | +134.8% | 38,081 | +86.5% | 0.03% | +146.2% |
Q2 2016 | $293,000 | +102.1% | 20,420 | +68.6% | 0.01% | +44.4% |
Q1 2016 | $145,000 | -54.1% | 12,114 | -58.9% | 0.01% | -70.0% |
Q3 2015 | $316,000 | – | 29,458 | – | 0.03% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Ulys, L.L.C. | 4,321,214 | $62,009,000 | 100.00% |
Artal Group S.A. | 57,517,977 | $825,383,000 | 17.04% |
NEA Management Company, LLC | 2,382,286 | $34,186,000 | 1.77% |
UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO | 35,714 | $512,000 | 1.49% |
BRIDGER MANAGEMENT, LLC | 1,029,926 | $14,779,000 | 0.95% |
FALCON POINT CAPITAL, LLC | 287,809 | $4,130,000 | 0.71% |
HANCOCK WHITNEY CORP | 664,025 | $9,529,000 | 0.40% |
KINGDON CAPITAL MANAGEMENT, L.L.C. | 494,380 | $7,094,000 | 0.39% |
ELLINGTON MANAGEMENT GROUP LLC | 11,700 | $168,000 | 0.23% |
Convergence Investment Partners, LLC | 114,157 | $1,638,000 | 0.22% |